Clinical Trials Browser

Phase 3 × Disease Progression × Bortezomib × Clear all

NCT01109004 2021-12-09

BMT CTN 0702

Phase 3 Completed

758 enrolled 21 charts

Hematologic Diseases, Multiple Myeloma, Disease Progression

NCT01191060 2019-04-18

IFM/DFCI2009

Phase 3 Completed

Disease Progression, Neoplasms, Plasma Cell